Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | EGF | 100 | ng/mL | 3 | IL3 | 42.0 | 89 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | IL3 | 43.0 | 79 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL3 | 69.5 | 70 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL3 | 113.0 | 75 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL3 | 48.0 | 75 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | IL3 | 40.0 | 74 | |
N2586 | JNK-IN-11 | 0.3 | uM | 3 | IL3 | 34.5 | 66 | ||||
RA2159 | 3 | IL3 | 42.5 | 94 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | IL3 | 41.0 | 69 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL3 | 40.0 | 82 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL3 | 41.0 | 63 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL3 | 40.5 | 68 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | IL3 | 48.0 | 59 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | IL3 | 42.0 | 81 | ||||
N2586 | 3 | IL3 | 40.0 | 56 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | IL3 | 40.0 | 83 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | IL3 | 43.0 | 77 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | IL3 | 131.5 | 80 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | IL3 | 115.0 | 79 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | IL3 | 36.5 | 68 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | IL3 | 42.0 | 63 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | IL3 | 41.0 | 83 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | IL3 | 38.0 | 79 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL3 | 45.0 | 80 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | IL3 | 43.0 | 61 |